Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jun;10(8):625-627.
doi: 10.2217/cer-2021-0050. Epub 2021 Apr 23.

Testing the efficacy of tocilizumab in patients with COVID-19 pneumonia

Affiliations
Editorial

Testing the efficacy of tocilizumab in patients with COVID-19 pneumonia

Mehmet Agirbasli et al. J Comp Eff Res. 2021 Jun.
No abstract available

Keywords: COVID-19; clinical trials; tocilizumab.

PubMed Disclaimer

Similar articles

References

    1. Gupta S, Wang W, Hayek SS et al. Association between early treatment with tocilizumab and mortality among critically ıll patients with COVID-19. JAMA Intern. Med. 181(1), 41–51 (2021). - PMC - PubMed
    1. Rosas IO, Bräu N, Waters M et al. Tocilizumab in hospitalized patients with severe Covid-19 pneumonia. N. Engl. J. Med. (2021) (Epub ahead of print). - PMC - PubMed
    1. Salvarani C, Dolci G, Massari M et al. Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: a randomized clinical trial. JAMA Intern. Med. 181(1), 24–31 (2021). - PMC - PubMed
    1. Hermine O, Mariette X, Tharaux PL et al. Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial. JAMA Intern. Med. 181(1), 32–40 (2021). - PMC - PubMed
    1. Stone JH, Frigault MJ, Serling-Boyd NJ et al. Efficacy of tocilizumab in patients hospitalized with Covid-19. N. Engl. J. Med. 383(24), 2333–2344 (2020). - PMC - PubMed

Publication types

Substances

LinkOut - more resources